12.1 Pharmacy DEA & OBNDD Registration Requirements

12.1 Pharmacy DEA & OBNDD Registration Requirements

The handling, procurement, storage, and dispensing of Controlled Dangerous Substances (CDS) in Oklahoma is strictly governed by a closed regulatory system designed to prevent diversion while ensuring legitimate patient access. This closed distribution framework operates through concurrent federal and state oversight. At the federal level, the Drug Enforcement Administration (DEA) enforces Title 21 of the United States Code (Controlled Substances Act - CSA) and Title 21 of the Code of Federal Regulations (21 CFR Parts 1300–1399). At the state level, the Oklahoma Bureau of Narcotics and Dangerous Drugs Control (OBNDD) enforces Title 63 of the Oklahoma Statutes (Uniform Controlled Dangerous Substances Act) and Title 475 of the Oklahoma Administrative Code (OAC 475), while the Oklahoma State Board of Pharmacy (OSBP) enforces practice and facility standards under Title 59 O.S. and OAC Title 535.

---

Tripartite Registration Hierarchy in Oklahoma

Before an Oklahoma pharmacy can legally order, store, or dispense a single dosage unit of any controlled substance in Schedules II through V, it must secure credentials in a strict statutory sequence:

1. Step 1: Oklahoma State Board of Pharmacy (OSBP) Facility License: The pharmacy must first obtain its Oklahoma retail, hospital, or non-resident pharmacy permit from the OSBP under Title 59 O.S. § 353.18. State licensure serves as the baseline prerequisite establishing operational fitness and designated Pharmacist-in-Charge (PIC) oversight.
2. Step 2: OBNDD State Controlled Substance Registration: Upon securing state board licensure, the pharmacy must apply for and obtain an annual state CDS registration from the OBNDD pursuant to Title 63 O.S. § 2-302 and OAC 475:10-1-1. OBNDD registration authorizes the facility to possess and distribute controlled substances within Oklahoma.
3. Step 3: Federal DEA Registration: With active state facility licensure and state CDS registration established, the pharmacy applies to the DEA for federal registration under 21 CFR § 1301.11. The DEA will not grant or maintain a federal registration without active, unencumbered state licensing authority.

+-------------------------------------------------------------------------+
|                 OKLAHOMA CDS REGISTRATION PREREQUISITES                 |
+-------------------------------------------------------------------------+
|   1. OSBP State Pharmacy License  -->  Foundational facility permit     |
|   2. OBNDD State CDS Registration -->  Annual state narcotic permit     |
|   3. DEA Federal Registration     -->  Triennial federal registration   |
+-------------------------------------------------------------------------+

---

Federal DEA Registration Framework (21 CFR Part 1301)

Under federal law, every person or entity that manufactures, distributes, dispenses, imports, exports, or conducts research with controlled substances must obtain a registration unless specifically exempted by statute.

DEA Application Forms & Registration Categories

DEA Registration Renewal Timeline & Mechanics

Federal DEA retail pharmacy registrations expire every 36 months (3 years). The renewal lifecycle follows strict administrative rules under 21 CFR § 1301.13:

• 60 Days Prior to Expiration: Registrants may renew their registration online at the DEA Diversion Control Division website no earlier than 60 calendar days prior to the current expiration date.
• 45 Days Prior to Expiration: If a registrant has not renewed electronically, the DEA will mail a renewal notice / application to the registered address approximately 45 days before expiration.
• 30 Days Prior to Expiration (Registrant Affirmative Duty): If the renewal form has not been received by the pharmacy within 30 days of the expiration date, the registrant has an affirmative legal duty to notify the DEA in writing and demand a renewal application.
• Expiration Date (Midnight): If a DEA registration expires, the pharmacy loses all legal authority to order, dispense, distribute, or possess controlled substances at 11:59:59 PM on the expiration date. Operating on an expired DEA registration constitutes an unlawful unauthorized distribution under the CSA. A grace period allows late renewal submission within 30 calendar days post-expiration, but no CDS activities may occur during that lapse until registration reinstatement is formally processed.

---

Separate Location & Activity Registration Mandates (21 CFR § 1301.12)

A separate DEA and OBNDD registration is legally required for each principal place of business or professional practice where controlled substances are manufactured, distributed, imported, exported, or dispensed:

• Physical Address Specificity: A pharmacy corporation operating five physical branch stores in Oklahoma City and Tulsa must secure five separate OSBP pharmacy licenses, five separate OBNDD registrations, and five separate DEA registrations. Registrations are tied to a specific physical street address and cannot be transferred from one building to another without prior regulatory authorization.
• Separate Activity Registrations: An entity registered to dispense CDS (such as a community pharmacy) cannot engage in manufacturing or wholesale distribution outside statutory exemptions without securing a separate distributor registration (DEA Form 225).
• Automated Dispensing Systems (ADS) at Long-Term Care Facilities (LTCFs): Under 21 CFR § 1301.17, a retail pharmacy that installs and operates an Automated Dispensing System at an LTCF must obtain a separate DEA registration for that specific LTCF physical location, using DEA Form 224.

The 5% Distribution Rule (21 CFR § 1307.11 / Title 63 O.S.)

A practitioner or community pharmacy registered as a dispenser may distribute a small quantity of controlled substances to another registered practitioner or pharmacy for general dispensing without registering as a wholesale distributor, provided that:

1. The receiving practitioner/pharmacy is registered with both the DEA and OBNDD to dispense controlled substances;
2. The transfer is properly documented (using a DEA Form 222 or CSOS for Schedule II drugs, or a commercial invoice for Schedule III–V drugs);
3. The 5% Threshold: The total number of dosage units of all controlled substances distributed by the pharmacy during any consecutive 12-month calendar period does not exceed 5% of the total number of dosage units of all controlled substances dispensed and distributed by the pharmacy during that same period.
4. If total distributions exceed 5%, the pharmacy must immediately register as a wholesale distributor under DEA Form 225 and OBNDD distributor rules.

---

Modification, Termination, and Transfer of DEA Registration

Modification of Registration (Change of Address or Name - 21 CFR § 1301.51)

If a pharmacy changes its physical address, mailing address, or legal corporate name, it must submit an application for modification of registration online or in writing to the DEA. The registrant cannot move controlled substances to the new physical location until the DEA approves the modification and issues an updated Certificate of Registration. The pharmacy must also secure prior written approval and an updated license/registration from the OSBP and OBNDD.

Termination of Registration (21 CFR § 1301.52)

When a pharmacy ceases legal existence, discontinues business, or permanently closes without transferring its operations:

• The DEA registration automatically terminates;
• The registrant must promptly surrender the Certificate of Registration and all unexecuted DEA Form 222s to the local DEA Special Agent in Charge (SAC);
• All controlled substance inventory must be properly disposed of via an authorized reverse distributor (documented on Form 222 / Form 41) or transferred to another registrant in compliance with federal and state rules.

Transfer of Business Operations (21 CFR § 1301.52)

When a pharmacy sells its business or transfers operations to another registered pharmacy entity, a strict notification and execution protocol applies:

1. 14-Day Advance Written Notice: The transferring registrant must submit written notification in person or by registered/certified mail to the DEA Special Agent in Charge (SAC) of the local DEA Field Division at least 14 calendar days prior to the proposed transfer date.
2. Required Notice Contents:
   • Name, physical address, DEA registration number, and state license/OBNDD numbers of both the transferor (seller) and transferee (acquirer);
   • Whether business activities will continue at the current registered location or be relocated;
   • The exact scheduled date on which the transfer of controlled substances will occur.
3. Presumed Approval: If the SAC does not notify the transferor that the transfer is denied prior to the scheduled date, the transfer may proceed as planned.
4. Mandatory Inventory on Transfer Date: On the exact date of transfer, a complete physical inventory of all controlled substances (Schedules II through V) must be taken at either the opening or closing of business. This inventory serves as the final closing inventory for the transferor and the initial opening inventory for the transferee. Both parties must retain a copy.
5. CDS Transfer Documentation:
   • Schedule II Substances: Transferred using DEA Form 222 (or CSOS), where the transferee (acquiring pharmacy) acts as the purchaser and issues the Form 222 to the transferor (selling pharmacy).
   • Schedule III–V Substances: Transferred using a commercial invoice reflecting the drug name, dosage form, strength, quantity, container count, date of transfer, and names, addresses, and DEA numbers of both parties.

---

Oklahoma OBNDD Registration Specifics (Title 63 O.S. & OAC Title 475)

In Oklahoma, the OBNDD maintains independent regulatory authority over controlled dangerous substances:

• Annual Registration Interval: Unlike the federal 3-year cycle, OBNDD registrations for pharmacies and individual prescribers must be renewed annually (every 1 year) under Title 63 O.S. § 2-302.
• Dual Registration Requirement: Every individual practitioner who prescribes CDS in Oklahoma must hold an active OBNDD registration, and every pharmacy dispensing CDS must maintain an active facility OBNDD registration.
• Revocation Linkage: Under OAC 475:10-1-9, any suspension, revocation, or restriction placed upon a pharmacy's OSBP license automatically serves as grounds for immediate suspension or revocation of its OBNDD registration. In turn, revocation of OBNDD authority triggers federal DEA administrative revocation under 21 U.S.C. § 824.

---

DEA Number Verification Math Formula & Algorithm

A pharmacist possesses a legal corresponding responsibility to ensure that all controlled substance prescriptions are issued by an authorized, properly registered prescriber. Verifying the authenticity of a prescriber's DEA registration number involves evaluating its structural format and executing a 9-step mathematical checksum formula.

Structural Format: 2 Alpha Characters + 7 Numeric Digits

$\text{DEA Number Format: } [\alpha_1][\alpha_2][D_1][D_2][D_3][D_4][D_5][D_6][D_7]$

1. First Letter ($\alpha_1$) — Practitioner / Business Classification

• A, B, F, G: Traditional primary practitioners (Physicians [MD/DO], Dentists [DDS/DMD], Veterinarians [DVM], Podiatrists [DPM]), retail and hospital pharmacies, clinics, and teaching institutions.
• M: Mid-Level Practitioners (MLPs), including Physician Assistants (PAs), Advanced Practice Registered Nurses (APRNs/Nurse Practitioners/CRNAs), and Optometrists (ODs).
• P, R: Manufacturers, wholesale distributors, reverse distributors, researchers, analytical laboratories, and narcotic treatment programs.
• X: Prescribers possessing a Drug Addiction Treatment Act of 2000 (DATA 2000) waiver for office-based treatment of opioid use disorder with buprenorphine (subsequently updated by the federal MATE Act, but historical X-waiver identifiers remain relevant for exam validation).

2. Second Letter ($\alpha_2$) — Prescriber Suffix / Surname

• The second alpha character corresponds to the first letter of the practitioner's legal last name at the time of initial registration (or the first letter of a corporate pharmacy's business name).
• Exception: If a practitioner legally changes their last name after marriage or court order, the DEA does not issue a new DEA number; therefore, the second letter will reflect their historical surname.

3. Seven-Digit Mathematical Checksum Algorithm

To verify the validity of the 7-digit numeric sequence $[D_1 D_2 D_3 D_4 D_5 D_6 D_7]$:

1. Step 1: Calculate the sum of the 1st, 3rd, and 5th digits: $S_1 = D_1 + D_3 + D_5$
2. Step 2: Calculate the sum of the 2nd, 4th, and 6th digits: $S_2 = D_2 + D_4 + D_6$
3. Step 3: Multiply the second sum ($S_2$) by 2: $P = S_2 \times 2$
4. Step 4: Add the first sum ($S_1$) to the product ($P$): $\text{Total} = S_1 + P = (D_1 + D_3 + D_5) + 2(D_2 + D_4 + D_6)$
5. Step 5 (Check Digit Verification): The rightmost (last) digit of the Total must be strictly identical to the 7th digit ($D_7$) of the DEA number.

$\text{Verification Condition: } \text{Total} \pmod{10} = D_7$

Worked Mathematical Example

Consider a controlled substance prescription written by Dr. Rachel Adams, MD, displaying DEA number BA 4829153:

• Prefix Validation: 'B' indicates a primary physician; 'A' matches the first letter of Adams.
• Step 1 (Odd Digits): $S_1 = 4 + 2 + 1 = 7$
• Step 2 (Even Digits): $S_2 = 8 + 9 + 5 = 22$
• Step 3 (Multiply Even Sum by 2): $P = 22 \times 2 = 44$
• Step 4 (Calculate Total): $\text{Total} = 7 + 44 = 51$
• Step 5 (Check Digit): The rightmost digit of $51$ is $1$. However, the 7th digit on the prescription is $3$. Because $1 \neq 3$, the DEA number is mathematically invalid and indicates an error, forgery, or fraudulent credential.